v3.26.3
Share-based Compensation (Tables)
 6 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The following table summarizes the components of total share-based compensation expense included in the condensed consolidated statements of operations for each period presented (in thousands):
Three Months Ended September 30,Six Months Ended September 30,
2026202520262025
Cost of revenue$10,394 $10,015 $19,760 $19,865 
Research and development30,648 29,718 60,164 56,579 
Sales and marketing21,609 22,576 41,496 42,610 
General and administrative15,510 14,505 30,317 29,655 
Total share-based compensation$78,161 $76,814 $151,737 $148,709 
Schedule of Restricted Stock Awards (RSA) and Restricted Stock Units (RSU)
The following table provides a summary of changes in the number of RSUs and restricted stock awards (“RSAs”) for the six months ended September 30, 2026:
Number of RSUs
Weighted Average
Grant Date Fair Value
Number of
 RSAs
Weighted Average
Grant Date Fair Value
(in thousands)(per share)(in thousands)(per share)
Balance, March 31, 202610,403 $51.96 61 $49.05 
Granted7,147 43.10 — — 
Vested(3,583)52.04 (30)49.05 
Forfeited(826)52.69 — — 
Balance, September 30, 202613,141 $47.06 31 $49.05 
Schedule of Activity for Stock Options The following table summarizes activity for stock options during the six months ended September 30, 2026:
Number of Options
Weighted Average
Exercise Price
Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
(in thousands)(per share)(years)(in thousands)
Balance, March 31, 20261,727 $22.11 
Exercised(243)21.29 
Forfeited or expired(4)49.68 
Balance, September 30, 20261,480 $22.18 3.0$52,634 
Options vested and expected to vest at September 30, 20261,480 $22.18 3.0$52,634 
Options vested and exercisable at September 30, 20261,480 $22.18 3.0$52,634